Elanco Animal Health is a drug manufacturers - specialty & generic business based in the US. Elanco Animal Health shares (ELAN) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $10.35 – a decrease of 1.9% over the previous week. Elanco Animal Health employs 9,000 staff and has a trailing 12-month revenue of around $4.4 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $10.35 |
|---|---|
| 52-week range | $10.03 - $18.80 |
| 50-day moving average | $11.25 |
| 200-day moving average | $13.13 |
| Wall St. target price | $15.09 |
| PE ratio | 15.3088 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.68 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $10.5 from 2025-03-31
| 1 week (2025-03-26) | -0.47% |
|---|---|
| 1 month (2025-03-03) | -7.16% |
| 3 months (2025-01-03) | -12.35% |
| 6 months (2024-10-03) | -27.59% |
| 1 year (2024-04-02) | -32.61% |
|---|---|
| 2 years (2023-03-31) | 11.70% |
| 3 years (2022-04-01) | 26.12 |
| 5 years (2020-04-02) | 20.77 |
Valuing Elanco Animal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Elanco Animal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Elanco Animal Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Elanco Animal Health shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Elanco Animal Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.3494. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Elanco Animal Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Elanco Animal Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $879 million.
The EBITDA is a measure of a Elanco Animal Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.4 billion |
|---|---|
| Operating margin TTM | 1.37% |
| Gross profit TTM | $2.4 billion |
| Return on assets TTM | 1.19% |
| Return on equity TTM | 5.49% |
| Profit margin | 7.61% |
| Book value | $12.33 |
| Market Capitalization | $5.1 billion |
TTM: trailing 12 months
We're not expecting Elanco Animal Health to pay a dividend over the next 12 months.
Over the last 12 months, Elanco Animal Health's shares have ranged in value from as little as $10.03 up to $18.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Elanco Animal Health's is 1.442. This would suggest that Elanco Animal Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.